APA

Spring M. D., Cummings J. F., Ockenhouse C. F., Dutta S., Reidler R., Angov E., Bergmann-Leitner E., Stewart V. A., Bittner S., Juompan L., Kortepeter M. G., Nielsen R., Krzych U., Tierney E., Ware L. A., Dowler M., Hermsen C. C., Sauerwein R. W., de Vlas S. J., Ofori-Anyinam O., Lanar D. E., Williams J. L., Kester K. E., Tucker K., Shi M., Malkin E., Long C., Diggs C. L., Soisson L., Dubois M., Ballou W. R., Cohen J. & Heppner D. G. (20090727). Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. : PloS one.

Chicago

Spring Michele D, Cummings James F, Ockenhouse Christian F, Dutta Sheetij, Reidler Randall, Angov Evelina, Bergmann-Leitner Elke, Stewart V Ann, Bittner Stacey, Juompan Laure, Kortepeter Mark G, Nielsen Robin, Krzych Urszula, Tierney Ev, Ware Lisa A, Dowler Megan, Hermsen Cornelus C, Sauerwein Robert W, de Vlas Sake J, Ofori-Anyinam Opokua, Lanar David E, Williams Jack L, Kester Kent E, Tucker Kathryn, Shi Meng, Malkin Elissa, Long Carole, Diggs Carter L, Soisson Lorraine, Dubois Marie-Claude, Ballou W Ripley, Cohen Joe and Heppner D Gray. 20090727. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. : PloS one.

Harvard

Spring M. D., Cummings J. F., Ockenhouse C. F., Dutta S., Reidler R., Angov E., Bergmann-Leitner E., Stewart V. A., Bittner S., Juompan L., Kortepeter M. G., Nielsen R., Krzych U., Tierney E., Ware L. A., Dowler M., Hermsen C. C., Sauerwein R. W., de Vlas S. J., Ofori-Anyinam O., Lanar D. E., Williams J. L., Kester K. E., Tucker K., Shi M., Malkin E., Long C., Diggs C. L., Soisson L., Dubois M., Ballou W. R., Cohen J. and Heppner D. G. (20090727). Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. : PloS one.

MLA

Spring Michele D, Cummings James F, Ockenhouse Christian F, Dutta Sheetij, Reidler Randall, Angov Evelina, Bergmann-Leitner Elke, Stewart V Ann, Bittner Stacey, Juompan Laure, Kortepeter Mark G, Nielsen Robin, Krzych Urszula, Tierney Ev, Ware Lisa A, Dowler Megan, Hermsen Cornelus C, Sauerwein Robert W, de Vlas Sake J, Ofori-Anyinam Opokua, Lanar David E, Williams Jack L, Kester Kent E, Tucker Kathryn, Shi Meng, Malkin Elissa, Long Carole, Diggs Carter L, Soisson Lorraine, Dubois Marie-Claude, Ballou W Ripley, Cohen Joe and Heppner D Gray. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. : PloS one. 20090727.